Rheumatology Doctors in Rockville, MD Accepting Medicare

8 Rheumatology doctors found. Showing 1 - 8

Ashley Beall, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 14995 Shady Grove Rd Ste 250, Rockville, MD 20850 Phone: 301-942-7600    Fax: 301-217-9241

Dr. Emma Giacinta Diiorio, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 14995 Shady Grove Rd, Suite 250, Rockville, MD 20850 Phone: 301-942-7600    Fax: 301-942-3132

Daniel Elbogdadi, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 14995 Shady Grove Rd, Suite 250, Rockville, MD 20850 Phone: 301-942-7600    Fax: 301-217-9241

Dr. Evan L Siegel, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 14995 Shady Grove Rd Ste 250, Rockville, MD 20850 Phone: 301-942-7600    Fax: 301-942-3521

Dr. Guada R Respicio Duque, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 14995 Shady Grove Rd Ste 250, Rockville, MD 20850 Phone: 301-942-7600    Fax: 301-217-9241

Omer N Pamuk, Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 9000 Rockville Pike, Building 10, Room 10n-311, Rockville, MD 20850 Phone: 857-928-6583

Dr. Lawrence H Schainker, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1201 Seven Locks Rd, Ste 111, Rockville, MD 20854 Phone: 301-762-5020    Fax: 301-294-7569

Dr. Louis Simchowitz, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1201 Seven Locks Rd, Suite 111, Rockville, MD 20854 Phone: 301-762-5020    Fax: 301-294-7569

News Archive

Honokiol extract holds promise as adjunct treatment for bladder and kidney cancers

The botanical extract honokiol, a biologically active molecule isolated from the bark of Magnolia spp., holds promise as an adjunct treatment for aggressive bladder and kidney cancers, as reported in two new studies. New research on honokiol in bladder cancer was presented at the American Association for Cancer Research Annual Meeting 2015.

Phase 2 RESONATE-17 study: IMBRUVICA (ibrutinib) improves survival in CLL patients with del 17p

Results from the Phase 2 RESONATE-17 (PCYC-1117) study show IMBRUVICA (ibrutinib) was associated with an 82.6 percent investigator-assessed overall response rate (ORR; the primary endpoint) and a 79 percent progression-free survival (PFS) rate at 12 months in people living with relapsed/refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have a genetic mutation known as deletion 17p (del 17p).

Sperm quality not affected by one course of postoperative treatment for early testicular cancer

Men with early stage testicular cancer can safely receive one course of chemotherapy or radiotherapy after surgery without it having a long-term effect on their sperm count, according to a study published in the leading cancer journal Annals of Oncology today (Monday).

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Moderate alcohol intake can reduce risk of asthma

Drinking alcohol in moderate quantities can reduce the risk of asthma, according to Danish researchers.

Read more Medical News

› Verified 2 days ago